Eisenhower Imaging Center patients who receive a chest CT scan will benefit from new AI-powered technology that will help identify potentially cancerous lung nodules. By leveraging Riverain Technologies ClearRead CT to suppress blood vessels, radiologists will have a clearer view of the chest, allowing early diagnosis of lung cancer, even among patients who don't have symptoms.
"The best outcomes for a lung cancer diagnosis come from early detection. With the ability to identify lung nodules in CT scans from asymptomatic patients, we can save lives by detecting lung cancer early," said Dr. Mehran Elly, MD, PhD, Interventional Radiologist at Eisenhower Imaging Center. "The growing concept of opportunistic screening in radiology allows us to maximize scans and provide patients with insights beyond their initial medical concern. Innovations like ClearRead bring that concept to reality with accurate results."
Eisenhower Imaging Center offers ClearRead on every adult chest CT scan at their outpatient imaging centers. Patients who meet lung cancer screening criteria can also receive a low-dose CT with ClearRead. By deploying ClearRead CT throughout the entire enterprise, improved detection of lung nodules can benefit those in screening programs and those seeking medical attention for other reasons. Screening and opportunistic detection is the most comprehensive method to provide patients with the best outcomes and treatment options.
Powered by machine learning and advanced modeling, Riverain's patented, FDA-cleared ClearRead CT software tools are powered by the most advanced AI methods available to the medical imaging market.
"Eisenhower Imaging Center is taking proactive steps to address early detection of lung cancer and save lives. When clinicians have an unimpaired view of a chest CT, with blood vessels suppressed, they can more quickly and precisely detect, quantify, and report pulmonary nodules," said Steve Worrell, CEO, Riverain Technologies. "Our ClearRead technology is helping hospitals and VA medical centers across the country with AI-powered, unimpaired views of chest imaging, so radiologists can focus on what matters to detect, precisely characterize, and report findings."